Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Mar 17, 2021 5:35pm
196 Views
Post# 32819457

RE:RE:Cell peer reviewed

RE:RE:Cell peer reviewed,,,if only we had some talent to grab the bull by the horns here and get the process in motion asap. The executives cheques keep on rolling in so they be in no real hurry,,,,,and we seem always to be late to the party,,,,,I hope I am wrong but our inexperienced team will more than likely stay true to form and fumble the ball at the line,,,,or get tackled ,,get up dazed and run across our touch down line with ball in hand!!!,,,nothing surprises me any more with DMcC and the team!! jmo,,all the while the data around covid and SARS/208 has been know for months with no action,,,all the above is based on our trial history, our lack of an aggresive business plan, the same old same old management team,,the investor interest in the new story and of course the telling point,,our share price!,,
<< Previous
Bullboard Posts
Next >>